CD86 and B-cell chronic lymphocytic leukemia: ROC analysis confirms the high diagnostic value of immune markers (PD-1, PD-L1, CTLA-4, CD200, CD86) and their soluble forms in distinguishing patients with CLL from healthy volunteers.